These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 6170758

  • 21. Allogeneic and associative recognition determinants of H-2 molecules.
    Clark SS, Forman J.
    Transplant Proc; 1983 Dec; 15(4):2090-2. PubMed ID: 6200976
    [Abstract] [Full Text] [Related]

  • 22. IA mutant functional antigen-presenting cell lines.
    Glimcher LH, Hamano T, Asofsky R, Sachs DH, Pierres M, Samelson LE, Sharrow SO, Paul WE.
    J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
    [Abstract] [Full Text] [Related]

  • 23. Changes in the Ir gene controlled response phenotypes in mice of the Ap and Ak family of alleles expressing naturally occurring variant molecules.
    Shaut DM, Wakeland EK, Maurer PH, Peck AB.
    J Immunol; 1984 Sep; 133(3):1410-6. PubMed ID: 6205082
    [Abstract] [Full Text] [Related]

  • 24. MHC-linked Ir gene control of T cell responses: GAT-specific proliferating T cells and helper T cells are elicited in nonresponder mice immunized with soluble GAT.
    Gougeon ML, Theze J.
    J Immunol; 1983 Apr; 130(4):1521-6. PubMed ID: 6187811
    [Abstract] [Full Text] [Related]

  • 25. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162.
    Oshima M, Atassi MZ.
    J Immunol; 1995 May 15; 154(10):5245-54. PubMed ID: 7537303
    [Abstract] [Full Text] [Related]

  • 26. The contribution of I-Abm12 to phenotypic and functional alterations among T-cell subsets in NZB mice.
    Naiki M, Yoshida SH, Watanabe Y, Izui S, Ansari AA, Gershwin ME.
    J Autoimmun; 1993 Apr 15; 6(2):131-43. PubMed ID: 8388689
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Insulin-specific tolerance induction. I. Abrogation of helper T cell activity is controlled by H-2-linked Ir genes.
    Robbins PF, Thomas JW, Jensen PE, Kapp JA.
    J Immunol; 1984 Jan 15; 132(1):43-9. PubMed ID: 6197454
    [Abstract] [Full Text] [Related]

  • 31. T cell-independent responses to an Ir gene-controlled antigen. I. Characteristics of the immune response to insulin complexed to Brucella abortus.
    Thomas JW, Bucy RP, Kapp JA.
    J Immunol; 1982 Jul 15; 129(1):6-10. PubMed ID: 6177760
    [Abstract] [Full Text] [Related]

  • 32. Immune responses to complex protein antigens I. MHC control of immune responses to bovine albumin.
    Riley RL, Wilson LD, Germain RN, Benjamin DC.
    J Immunol; 1982 Oct 15; 129(4):1553-8. PubMed ID: 6180016
    [Abstract] [Full Text] [Related]

  • 33. B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.
    McKenzie IF, Morgan GM, Sandrin MS, Michaelides MM, Melvold RW, Kohn HI.
    J Exp Med; 1979 Dec 01; 150(6):1323-38. PubMed ID: 159937
    [Abstract] [Full Text] [Related]

  • 34. [Genetic control of the immune response to Streptococcus mutans, insulins and (T,G)-A--L in the rat].
    Inomata T.
    Hokkaido Igaku Zasshi; 1983 Jul 01; 58(4):406-19. PubMed ID: 6195063
    [Abstract] [Full Text] [Related]

  • 35. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL, Mendell N, Kahn CR, Johnson AH, Rosenthal A.
    J Clin Invest; 1983 Sep 01; 72(3):1130-8. PubMed ID: 6411767
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun 01; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 38. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K.
    Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722
    [Abstract] [Full Text] [Related]

  • 39. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA, Ahmed R, Oldstone MB.
    J Immunol; 1984 Jul 15; 133(1):433-9. PubMed ID: 6202788
    [Abstract] [Full Text] [Related]

  • 40. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
    von der Weid T, Beebe AM, Roopenian DC, Coffman RL.
    J Immunol; 1996 Nov 15; 157(10):4421-7. PubMed ID: 8906817
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.